Only advances that occurred from 2011 to 2014 that either strengthen the previous 2011
guidelines [1, 2] or lead to changes or additional guidelines are reviewed here. Advances …

Only advances that occurred from 2011–2014 that either strengthen the previous 2011
guidelines [1; 2] or lead to changes or additional guidelines are reviewed here. Advances …

Background The diagnostic work-up and treatment of patients with gastroenteropancreatic
(GEP) neuroendocrine neoplasms (NEN) has undergone major advances and new methods …

This ENETS guidance paper for well‐differentiated nonfunctioning pancreatic
neuroendocrine tumours (NF‐Pan‐NET) has been developed by a multidisciplinary working …

Abstract Background Neuroendocrine tumors (NETs) are rare neoplasms, with an estimated
annual incidence of~ 6.9/100,000. NETs arise throughout the body from cells of the diffuse …

Pancreatic neuroendocrine tumors (pNETs) are rare heterogeneous tumors that have been
steadily increasing in both incidence and prevalence during the past few decades …

Progress in the diagnostics and therapy of gastro-entero-pancreatic (GEP) neuroendocrine
neoplasms (NEN), the published results of new randomised clinical trials, and the new …

R. Garcia-Carbonero a H. Sorbye b E. Baudin c E. Raymond d B. Wiedenmann e B. Niederle
f E. Sedlackova g C. Toumpanakis h M. Anlauf i JB Cwikla j M. Caplin k D. O'Toole l A …

This article is the result of the North American Neuroendocrine Tumor Society consensus
conference on the medical management of pancreatic neuroendocrine tumors from July 19 …

Background. The diagnostic work-up and treatment of patients with neuroendocrine
neoplasms (NENs) has undergone major recent advances and new methods are currently …